Lillian Smith

VP, Corporate Counsel, Allogene Therapeutics, Inc.

Companies

Allogene Therapeutics, Inc.VP, Corporate Counsel Apr 5, 2023 to Apr 5, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Allogene Therapeutics, Inc. ALLO83,845 shares²$107.5K at $1.28Apr 5, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 1, 2023Granted 56,545 shares of Allogene Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAllogene Therapeutics, Inc., VP, Corporate Counsel
2
SEC EDGARAllogene Therapeutics, Inc. shares after the filing of Apr 5, 2023
3
SEC EDGARForm 4 filed Apr 5, 2023